$JILL

J.Jill, Inc. (JILL): Results of Operations and Financial Condition

J.Jill, Inc. (JILL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jill-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 J.JILL, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS Provides Q2 FY26 Outlook Reaffirms Full Year FY26 Sales and Adjusted EBITDA* Outlook Quincy, Mass – June 10, 2026 – J.Jill, Inc. (NYSE:JILL) ("J.Jill" or the "Company") today

Original reporting
Published Jun 10, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 11:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$JILL
Bearish
high confidence
Mentioned
$JILL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$JILLBearishMed
01

Why it matters

The filing quantifies deterioration in sales, gross margin, operating income, and adjusted EBITDA versus the prior year, and it provides Q2 guidance with tariff-incorporated gross margin and EBITDA ranges.

02

Market read

Fresh earnings/guidance with explicit tariff assumptions and Q2 ranges makes this actionable for positioning around margin and EBITDA expectations.

03

What to watch

Inventory includes ~$5.5M of net tariff costs and free cash flow was an outflow; traders may need to watch working-capital normalization and whether tariff reimbursement timing changes the effective cost.

Relevance 7/10Novelty 9/10Timing: Filed June 10, 2026 (Q1 results + Q2 guidance just released)

Background

This is an SEC 8-K with Q1 FY26 operating results and an outlook section that explicitly models tariff rates by inventory receipt date.

Company-level read

Ticker impact

$JILLBearishHigh confidence
Context

J.Jill reports Q1 FY26 results and provides Q2 guidance, including tariff-driven gross margin pressure and EBITDA outlook.

Expected impact

Near-term bias toward downside/underperformance versus prior expectations unless investors focus on reaffirmed full-year targets and any stabilization in comparable sales.

Evidence & confidence

The filing contains fresh, company-specific financial results plus explicit Q2 guidance ranges and tariff assumptions that directly affect earnings power and sentiment.

Market effects

Tariff cost and gross-margin sensitivity highlighted by a specialty retailer can influence read-across for apparel/retail peers with similar import exposure.

Limited; company-specific US retailer update with no stated regional macro catalyst.

Moderate via trade/tariff uncertainty framing, but no new global policy decision disclosed.

Counterpoint

Investors may discount the Q2 margin hit if the company’s full-year outlook is reaffirmed and if early indicators of strategy traction offset near-term comps weakness.

Key entities

  • J.Jill, Inc.

    Reports Q1 FY26 results, provides Q2 guidance, and reaffirms full-year outlook while modeling tariff impacts.

  • Mary Ellen Coyne

    CEO/President quoted on strategy traction and gradual sequential improvement.

Related articles

$JILLMedAI 8/10

J.Jill Reaffirms FY26 Outlook, But Stock Plunges 7.6%

J.Jill reported first-quarter results and set Q2 guidance, expecting net sales to fall 1%–3% and comparable sales to decline 2%–4%. The company also reaffirmed its FY2026 outlook for net sales flat to down 2% and comparable sales down 1%–3%, based on assumed reciprocal tariff rates and lower second-half inventory purchases. The stock fell about 7.6% premarket to $12.10.

$NSPRMed

InspireMD, Inc. (NSPR): Results of Operations and Financial Condition

InspireMD, Inc. (NSPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 InspireMD Reports Second Quarter 2026 Financial Results - Company to host investor conference call today, August 17 th , at 8:30am EDT - Miami, FL — August 17, 2026 – InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), develope

$TSEMMed

Tower Semiconductor Misses Expectations but Guides to a Record $520M Quarter

Tower Semiconductor reported Q3 2026 EPS of $0.79, missing expectations and ending a five-quarter earnings beat streak. Revenue rose 16.3% year over year, supported by higher-value silicon photonics shipments and gross margin improvement. Management guided to a record $520M revenue quarter and said long-term customer advances rose to $145.4M. Japan expansion plans include METI-backed 300mm silicon photonics manufacturing.

$PROPMed

Prairie Operating Co. (PROP): Results of Operations and Financial Condition

Prairie Operating Co. (PROP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ef20079578_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Prairie Operating Co. Announces Second Quarter 2026 Results Houston, Texas, August 17, 2026 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company,” “Prairie,” “we,” “our,” or “us”) – an independent energy c